Human Myocardial Beta-adrenoceptors: Demonstration of Both Beta 1- and Beta 2-adrenoceptors Mediating Contractile Responses to Beta-agonists on the Isolated Right Atrium
Overview
Affiliations
On the isolated electrically driven muscle strip of human right atrial appendages the beta-adrenoceptor subtypes mediating the positive inotropic effects of isoprenaline, dobutamine and procaterol were characterized using the beta 1-selective antagonist bisoprolol and the beta 2-selective antagonist ICI 118,551. The three agonists induced concentration-dependent increases in force of contraction with an order of potency: procaterol (pD2-value: 8.03) greater than isoprenaline (pD2-value: 7.73) greater than dobutamine (pD2-value: 5.44). In saturating concentrations all three agonists produced the same maximum of developed tension. ICI 118,551 (10(-9)--10(-7) mol/l) and bisoprolol (10(-9)--10(-7) mol/l) were nearly equipotent in antagonizing the positive inotropic effects of isoprenaline and dobutamine. However, the slopes of the Schild-plots for both antagonists against both agonists were significantly less than 1.0 indicating interaction with beta 1- and beta 2-adrenoceptors. On the other hand, ICI 118,551 (10(-10)--10(-8) mol/l) was approximately 100 times more potent than bisoprolol (10(-8)--10(-6) mol/l) in antagonizing the positive inotropic effect of the highly selective beta 2-agonist procaterol. In addition, the slopes of the Schild-plots for antagonism of ICI 118,551 and bisoprolol against procaterol were not significantly different from unity indicating interaction with a homogeneous class of beta-adrenoceptors. The pA2-value for ICI 118,551 was 9.49, for bisoprolol it amounted to 6.99.(ABSTRACT TRUNCATED AT 250 WORDS)
The influence of diabetes on cardiac beta-adrenoceptor subtypes.
Altan V, Arioglu E, Guner S, Ozcelikay A Heart Fail Rev. 2007; 12(1):58-65.
PMID: 17364227 DOI: 10.1007/s10741-007-9005-6.
Hildebrand B, Wissler B, Olenik C, Meyer D Naunyn Schmiedebergs Arch Pharmacol. 1996; 354(4):404-10.
PMID: 8897441 DOI: 10.1007/BF00168429.
Ferro A, Kaumann A, Brown M Br J Pharmacol. 1993; 109(4):1053-8.
PMID: 8104641 PMC: 2175776. DOI: 10.1111/j.1476-5381.1993.tb13728.x.
Hernandez J, Pinto F, Figueira M, Riberio J Br J Pharmacol. 1994; 111(4):1316-20.
PMID: 8032618 PMC: 1910119. DOI: 10.1111/j.1476-5381.1994.tb14888.x.
Adie E, Milligan G Biochem J. 1994; 303 ( Pt 3):803-8.
PMID: 7980449 PMC: 1137618. DOI: 10.1042/bj3030803.